Sign Up Today and Learn More About Gallant Stock
Invest in or calculate the value of your shares in Gallant or other pre-IPO companies through EquityZen's platform.
Gallant Stock
Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.
About Gallant Stock
Founded
2018
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Gallant Press Mentions
Stay in the know about the latest news on Gallant
Ready-to-use stem cell kits for pets coming soon? Gallant closes $18M Series B funding
indianexpress • Jul 06, 2025
Ready-made stem cell therapies for pets could be coming
TechCrunch • Jul 05, 2025
Gallant fetches $18m to advance regenerative medicine for pets
longevity • Jul 04, 2025
Gallant: $18 Million Series B Raised For Ready-To-Use Stem Cell Therapies For Pets
pulse2 • Jul 03, 2025
Gallant Closes $18 Million Series B
vcnewsdaily • Jul 01, 2025
Gallant Management
Leadership team at Gallant
Marketing Director
Sara Woods
CEO
Linda Black
Join now and verify your accreditation status to gain access to:
- Gallant Current Valuation
- Gallant Stock Price
- Gallant Management
- Available deals in Gallant and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Gallant Cap Table and Funding History by Share Class and Liquidity Preferences
- Gallant Revenue and Financials
- Gallant Highlights
- Gallant Business Model
- Gallant Risk Factors
- Gallant Research Report from SACRA Research
Trading Gallant Stock
How to invest in Gallant stock?
Accredited investors can buy pre-IPO stock in companies like Gallant through EquityZen funds. These investments are made available by existing Gallant shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Gallant stock?
Shareholders can sell their Gallant stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."